Department of Anesthesiology and Pain Management, Maastricht University Medical Center+, Prof. Debyelaan 25, 6202 AZ Maastricht, Netherlands.
Department of Anesthesiology and ICU, St. Antonius Ziekenhuis, Postbus 2500, 3430 EM Nieuwegein, Netherlands.
Biomed Res Int. 2017;2017:2635151. doi: 10.1155/2017/2635151. Epub 2017 Oct 9.
Evaluation of accuracy, precision, and trending ability of cardiac index (CI) measurements using the Aesculon™ bioimpedance electrical cardiometry (Aesc) compared to the continuous pulmonary artery thermodilution catheter (PAC) technique before, during, and after cardiac surgery.
A prospective observational study with fifty patients with ASA 3-4. At six time points (T), measurements of CI simultaneously by continuous cardiac output pulmonary thermodilution and thoracic bioimpedance and standard hemodynamics were performed. Analysis was performed using Bland-Altman, four-quadrant plot, and polar plot methodology.
CI obtained with pulmonary artery thermodilution and thoracic bioimpedance ranged from 1.00 to 6.75 L min and 0.93 to 7.25 L min, respectively. Bland-Altman analysis showed a bias between CI and CI of 0.52 liters min m, with LOA of [-2.2; 1.1] liters min m. Percentage error between the two techniques was above 30% at every time point. Polar plot methodology and 4-quadrant analysis showed poor trending ability. Skin incision had no effect on the results.
CI obtained by continuous PAC and CI obtained by Aesculon bioimpedance are not interchangeable in cardiac surgical patients. No effects of skin incision were found. International clinical trial registration number is ISRCTN26732484.
在心脏手术前、中、后,评估使用 Aesculon™生物电阻抗心排量测定仪(Aesc)的心脏指数(CI)测量的准确性、精密度和趋势能力,并与连续肺动脉热稀释导管(PAC)技术进行比较。
一项前瞻性观察研究,共纳入 50 名 ASA 3-4 级的患者。在六个时间点(T),同时通过连续心输出量肺动脉热稀释和胸部生物电阻抗以及标准血液动力学进行 CI 测量。使用 Bland-Altman、四象限图和极坐标图方法进行分析。
肺动脉热稀释和胸部生物电阻抗测量的 CI 范围分别为 1.00 至 6.75 L/min 和 0.93 至 7.25 L/min。 Bland-Altman 分析显示 CI 与 CI 之间存在 0.52 升/分钟/米的偏差,LOA 为 [-2.2; 1.1] 升/分钟/米。两种技术之间的百分比误差在每个时间点均高于 30%。极坐标图方法和四象限分析显示趋势能力较差。皮肤切口对结果无影响。
在心脏外科患者中,连续 PAC 获得的 CI 和 Aesculon 生物电阻抗获得的 CI 不能互换。未发现皮肤切口的影响。国际临床试验注册号为 ISRCTN26732484。